A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria

被引：46

作者：

Slama, TG

Amin, A

Brunton, SA

File, TM

Milkovich, G

Rodvold, KA

Sahm, DF

Varon, J

Weiland, D

机构：

[1] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Div Internal Med, Dept Internal Med, Akron, OH 44304 USA

[2] Indiana Univ, Sch Med, Dept Infect Dis, Indianapolis, IN USA

[3] Univ Calif Irvine, Irvine Med Ctr, Dept Med, Orange, CA 92668 USA

[4] Carolinas Med Ctr, Dept Family Med, Charlotte, NC 28203 USA

[5] RJM & Associates, Woodbridge, VA USA

[6] Univ Illinois, Coll Pharm, Chicago, IL USA

[7] Univ Illinois, Coll Med, Chicago, IL USA

[8] Focus Technol Inc, Herndon, VA USA

[9] Univ Texas, Hlth Sci Ctr, Houston, TX USA

[10] Univ S Florida, Dept Family Med, Largo, FL USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2005年 / 118卷

关键词：

antibiotic therapy resistance; antibiotics; antimicrobials;

D O I：

10.1016/j.amjmed.2005.05.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In response to the overuse and misuse of antibiotics, leading to increasing bacterial resistance and decreasing development of new antibiotics, the Council for Appropriate and Rational Antibiotic Therapy (CARAT) has developed criteria to guide appropriate and accurate antibiotic selection. The criteria, which are aimed at optimizing antibiotic therapy, include evidence-based results, therapeutic benefits, safety, optimal drug for the optimal duration, and cost-effectiveness. (C) 2005 Elsevier Inc. All rights reserved.

引用

页码：1 / 6

页数：6

共 55 条

[1] AGARWAL G, 2004, IN PRESS BMJ, V328, P1066
[2] Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
Ambrose, PG
Grasela, DM
Grasela, TH
Passarell, J
Mayer, HB
Pierce, PF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) : 2793 - 2797
[3] Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections
Andes, D
[J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (02) : 165 - 172
[4] Antimicrobial treatment guidelines for acute bacterial rhinosinusitis - Executive summary
Anon, JB
Jacobs, MR
Roche, R
Poole, MD
Merck, D
Ambrose, PG
Benninger, MS
Hadley, JA
Craig, WA
Andes, DR
Bernstein, JM
Besser, RE
Dowell, SF
Drusano, GL
Klepser, ME
Nicolau, D
Radowsky, A
Reller, LB
Wald, ER
Zucker, DR
[J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 130 (01) : 1 - 45
[5] The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
Austin, DJ
Kristinsson, KG
Anderson, RM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) : 1152 - 1156
[6] Awasthi S, 2004, BMJ-BRIT MED J, V328, P791
[7] LENGTH OF ANTIBIOTIC-THERAPY IN IN-PATIENTS WITH PRIMARY PNEUMONIAS
AWUNORRENNER, C
[J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1979, 73 (03): : 235 - 240
[8] Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence
Ball, P
Baquero, F
Cars, O
File, T
Garau, J
Klugman, K
Low, DE
Rubinstein, E
Wise, R
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) : 31 - 40
[9] Balter Meyer S, 2003, Can Respir J, V10, P248
[10] Balter Meyer S, 2003, Can Respir J, V10 Suppl B, p3B

← 1 2 3 4 5 6 →